16:58 ETInvestor Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the Firmprnewswire·1 day ago, 04:00 PMALNY-1.77%
Why the Alnylam sell-off looks overdone -- and what investors are missingMSN·1 day ago, 06:00 AMALNY-1.77%
NASDAQ: ALNY Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Investors to Contact the FirmMorningStar·Aug 14 at 05:30 PMALNY-1.77%
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $256.00 Price Target at Wells Fargo & CompanyMarket Beat·Aug 14 at 09:48 AMALNY-1.77%
BridgeBio’s Attruby cruises toward blockbuster landFiercepharma·Aug 11 at 10:23 AMBBIO+0.04%IONS+2.43%
$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Todaybenzinga_article·Aug 10 at 09:00 AMALNY-1.77%
04:28 ETALNY Investors Have Opportunity to Join Alnylam Pharmaceuticals, Inc. Fraud Investigation with SBS Lawprnewswire·Aug 5 at 03:28 AMALNY-1.77%
ALNY Investors Have Opportunity to Join Alnylam Pharmaceuticals, Inc. Fraud Investigation with SBS LawMorningStar·Aug 3 at 05:33 PMALNY-1.77%
Raymond James Financial Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to "Strong-Buy"Market Beat·Aug 3 at 08:06 AMALNY-1.77%
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Lowered to $350.00 at Royal Bank Of CanadaMarket Beat·Jul 31 at 01:18 PMALNY-1.77%RY-0.17%
Morgan Stanley Issues Pessimistic Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock PriceMarket Beat·Jul 31 at 12:36 PMALNY-1.77%MS+0.39%
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Lowered to $350.00 at OppenheimerMarket Beat·Jul 31 at 11:24 AMALNY-1.77%
Alnylam’s $3.31 Billion Investment Portfolio Faces Rising Credit, Market and Interest Rate RisksTip Ranks·Jul 31 at 01:00 AMALNY-1.77%
